Initial studies in experimental GVHD models suggested that cytotoxicity mediated by cytotoxic T lymphocytes (CTLs) have a central role in GVHD target tissue injury through the Fas/Fas ligand pathway and perforin/granzyme pathways (101–104). The gene discussed is FAS; the disease is graft versus host disease.